Skip to main content

Accuray Incorporated

corporate_fare Company Profile

Accuray Incorporated

ARAY·NASDAQ·Industrial Applications And Services·CIK 0001138723

Accuray Incorporated is a radiation therapy company that develops, manufactures, sells, and supports solutions for treatment delivery, planning, imaging, and data management. These solutions are designed to assist clinical teams in providing precise radiation treatments for a wide variety of clinical cases. The company's product portfolio features the CyberKnife robotic platform and a distinct helical portfolio, which includes the Accuray Stellar, Radixact, Accuray Helix, and Tomo C Systems, where available. These solutions aim to provide clinicians with advanced capabilities for accuracy, flexibility, motion management, image guidance, adaptive workflows, and personalized treatment delivery. Accuray's solutions support clinical teams throughout individual treatments, across the treatment workflow, and during the entire patient treatment journey, from curative to palliative care. Across both its robotic and helical platforms, the solutions include radiation therapy systems with software-enabled motion management for real-time adaptation of treatment delivery for moving targets. They also offer treatment planning software that allows clinicians to utilize Accuray systems' capabilities to create high-quality treatment plans and support precise, efficient treatment delivery. ClearRT helical kVCT imaging technology, available on selected systems and configurations, produces high-quality CT images efficiently, with imaging length capabilities up to 135 cm on selected configurations, supporting broad anatomical visualization and adaptive treatment workflows. Automated tools help clinicians identify anatomical changes during treatment, evaluate the benefit of re-planning, and adapt radiation dose. Software tools also support efficient retreatment planning by evaluating prior dose information, generating new treatment plans, and assessing cumulative dose for patients who have previously received radiation therapy. The system architecture accommodates third-party surface guidance interfaces for patient positioning, monitoring positioning accuracy, and enabling deep inspiration breath hold ("DIBH") workflows for selected cancer treatments.

Accuray Incorporated (NASDAQ:ARAY) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 27 items for ARAY at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Accuray Reports Steep Q2 Losses, Revenue Decline Amid Restructuring and Nasdaq Delisting Threat
  • Accuray Restates Q1 Financials, Reveals Massive RPO Reduction and Material Internal Control Weaknesses
  • Accuray Restates Financials, Discloses Material Weaknesses in Internal Controls, Receives Adverse Auditor Opinion
  • Accuray Declares Non-Reliance on Past Financials, Citing Material Weaknesses
  • Accuray Receives Nasdaq Delisting Notice for Failing Minimum Bid Price Rule

Financial Snapshot

Fiscal year ended June 30, 2026
Revenue
$401.95M
Net Income
-$49.19M
Op. Cash Flow
-$6.98M
Free Cash Flow
-$12.84M
Gross Profit
$111.45M
Operating Income
-$26.44M
Cash & Equivalents
$40.62M
Total Debt
$147.87M
Debt / Equity
3.55×
Net Margin
-12.2%
Shares Outstanding
119.43M sh
Source: 10-K · filed 2026-08-27 · accession 0001437749-26-029098
$0.2501 -0.00% today
52-week range · as of 2026-08-27 $0.22 – $2.1
Market cap
$29.88M
Volume
698.4K (1.0× avg)
3-mo avg 698K
Live data · 2026-09-13 11:06 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ARAY - Filings & News (Page 2)

ARAY
Feb 17, 2026, 6:20 AM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.5776
Real-time Price: $0.2501 info
Change: -$0.3275 (-57%) info
Market Cap: $29.884M info
ARAY
Feb 17, 2026, 6:18 AM EST
Filing Type: 10-Q/A
Importance Score:
9
Price at Filing: $0.5776
Real-time Price: $0.2501 info
Change: -$0.3275 (-57%) info
Market Cap: $29.884M info
ARAY
Feb 17, 2026, 6:17 AM EST
Filing Type: 10-K/A
Importance Score:
9
Price at Filing: $0.5776
Real-time Price: $0.2501 info
Change: -$0.3275 (-57%) info
Market Cap: $29.884M info
ARAY
Feb 09, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.578
Real-time Price: $0.2501 info
Change: -$0.3279 (-57%) info
Market Cap: $29.884M info
ARAY
Feb 06, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.620
Real-time Price: $0.2501 info
Change: -$0.3699 (-60%) info
Market Cap: $29.884M info
ARAY
Feb 04, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.750
Real-time Price: $0.2501 info
Change: -$0.4999 (-67%) info
Market Cap: $29.884M info
ARAY
Jan 20, 2026, 5:00 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.8144
Real-time Price: $0.2501 info
Change: -$0.5643 (-69%) info
Market Cap: $29.884M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets